5 results on '"Hübers, Annemarie"'
Search Results
2. Comprehensive analysis of the mutation spectrum in 301 German ALS families
- Author
-
Müller, Kathrin, Brenner, David, Kubisch, Christian, Klopstock, Thomas, Zeller, Daniel, Jablonka, Sibylle, Sendtner, Michael, Klebe, Stephan, Knehr, Antje, Günther, Kornelia, Weis, Joachim, Claeys, Kristl G, Weydt, Patrick, Schrank, Berthold, Sperfeld, Anne-Dorte, Hübers, Annemarie, Otto, Markus, Dorst, Johannes, Meitinger, Thomas, Strom, Tim M, Andersen, Peter M, Ludolph, Albert, Weishaupt, Jochen H, Meyer, Thomas, MND-NET, German ALS network, Weyen, Ute, Hermann, Andreas, Regensburger, Martin, Winkler, Jürgen, Linker, Ralf, Winner, Beate, Hagenacker, Tim, Koch, Jan Christoph, Lingor, Paul, Grehl, Torsten, Göricke, Bettina, Zierz, Stephan, Jordan, Berit, Baum, Petra, Wolf, Joachim, Winkler, Andrea, Young, Peter, Bogdahn, Ulrich, Prudlo, Johannes, Kassubek, Jan, Petri, Susanne, Danzer, Karin M, Grosskreutz, Julian, Schuster, Joachim, Volk, Alexander E, and Borck, Guntram
- Subjects
0301 basic medicine ,DNA Mutational Analysis ,Medizin ,German ,0302 clinical medicine ,Superoxide Dismutase-1 ,Germany ,genetics ,Amyotrophic lateral sclerosis ,Exome sequencing ,Genetics ,Amyotrophic Lateral Sclerosis ,Whole Exome Sequencing ,TDP-43 protein, human ,TBK1 protein, human ,Protein-Serine-Threonine Kinases ,Pedigree ,genetics [Superoxide Dismutase-1] ,DNA-Binding Proteins ,Psychiatry and Mental health ,Editorial Commentary ,genetics [Amyotrophic Lateral Sclerosis] ,Mutation (genetic algorithm) ,symbols ,language ,Genotype ,genetics [Protein Serine-Threonine Kinases] ,genetics [DNA-Binding Proteins] ,Biology ,Protein Serine-Threonine Kinases ,genetics [Protein-Serine-Threonine Kinases] ,03 medical and health sciences ,symbols.namesake ,medicine ,Humans ,Genetic Predisposition to Disease ,ddc:610 ,Gene ,genetics [C9orf72 Protein] ,C9orf72 Protein ,medicine.disease ,language.human_language ,030104 developmental biology ,Mutation ,Mendelian inheritance ,RNA-Binding Protein FUS ,Surgery ,Neurology (clinical) ,Als ,genetics [RNA-Binding Protein FUS] ,030217 neurology & neurosurgery - Abstract
ObjectivesRecent advances in amyotrophic lateral sclerosis (ALS) genetics have revealed that mutations in any of more than 25 genes can cause ALS, mostly as an autosomal-dominant Mendelian trait. Detailed knowledge about the genetic architecture of ALS in a specific population will be important for genetic counselling but also for genotype-specific therapeutic interventions.MethodsHere we combined fragment length analysis, repeat-primed PCR, Southern blotting, Sanger sequencing and whole exome sequencing to obtain a comprehensive profile of genetic variants in ALS disease genes in 301 German pedigrees with familial ALS. We report C9orf72 mutations as well as variants in consensus splice sites and non-synonymous variants in protein-coding regions of ALS genes. We furthermore estimate their pathogenicity by taking into account type and frequency of the respective variant as well as segregation within the families.Results49% of our German ALS families carried a likely pathogenic variant in at least one of the earlier identified ALS genes. In 45% of the ALS families, likely pathogenic variants were detected in C9orf72, SOD1, FUS, TARDBP or TBK1, whereas the relative contribution of the other ALS genes in this familial ALS cohort was 4%. We identified several previously unreported rare variants and demonstrated the absence of likely pathogenic variants in some of the recently described ALS disease genes.ConclusionsWe here present a comprehensive genetic characterisation of German familial ALS. The present findings are of importance for genetic counselling in clinical practice, for molecular research and for the design of diagnostic gene panels or genotype-specific therapeutic interventions in Europe.
- Published
- 2018
3. Hot-spot KIF5A mutations cause familial ALS
- Author
-
Brenner, David, Yilmaz, Rüstem, Weber, Markus, Pinto, Susana, Claeys, Kristl, Schrank, Berthold, Jordan, Berit, Knehr, Antje, Günther, Kornelia, Hübers, Annemarie, Zeller, Daniel, Kubisch, Christian, Müller, Kathrin, Jablonka, Sibylle, Sendtner, Michael, Klopstock, Thomas, de Carvalho, Mamede, Sperfeld, Anne, Borck, Guntram, Volk, Alexander E., Dorst, Johannes, Weis, Joachim, Otto, Markus, Grehl, Torsten, Schuster, Joachim, Del Tredici, Kelly, Braak, Heiko, Danzer, Karin M., Freischmidt, Axel, Meitinger, Thomas, Strom, Tim M., Ludolph, Albert C., Andersen, Peter M., Weishaupt, Jochen H., Petri, Susanne, German ALS network MND-NET, Weyen, Ute, Hermann, Andreas, Hagenacker, Tim, Koch, Jan Christoph, Lingor, Paul, Göricke, Bettina, Zierz, Stephan, Baum, Petra, Wolf, Joachim, Meyer, Thomas, Winkler, Andrea, Young, Peter, Bogdahn, Ulrich, Prudlo, Johannes, Kassubek, Jan, Grosskreutz, Julian, Weydt, Patrick, Ruf, Wolfgang, Neuwirth, Christoph, and Hagenacker, Tim (Beitragende*r)
- Subjects
Male ,0301 basic medicine ,DNA Mutational Analysis ,genetics [Kinesin] ,Medizin ,whole exome sequencing ,AMYOTROPHIC LATERAL SCLEROSIS 1 ,0302 clinical medicine ,Spastic ,Missense mutation ,Exome sequencing ,Genetics ,food and beverages ,Kinesin ,Middle Aged ,Phenotype ,3. Good health ,genetics [Amyotrophic Lateral Sclerosis] ,metabolism [Lymphocytes] ,Female ,axonal transport ,Neurovetenskaper ,KIF5A mutations ,Adult ,musculoskeletal diseases ,congenital, hereditary, and neonatal diseases and abnormalities ,genetics [Kinesins] ,genetics [Mutation] ,Biology ,metabolism [RNA, Messenger] ,genetics [RNA, Messenger] ,03 medical and health sciences ,Humans ,ddc:610 ,RNA, Messenger ,Gene ,Genetic Association Studies ,Aged ,Family Health ,Neurosciences ,Original Articles ,drug effects [Lymphocytes] ,nervous system diseases ,Family member ,030104 developmental biology ,Neurology (clinical) ,ALS ,030217 neurology & neurosurgery ,KIF5A protein, human - Abstract
Brenner et al. show that mutations in a C-terminal hotspot of kinesin-5A (KIF5A) can cause a classical ALS phenotype. Experiments using patient-derived cell lines suggest haploinsufficiency as the molecular genetic mechanism. This underlines the relevance of intracellular transport processes for ALS, and is important for clinico-genetic diagnosis and counselling., Heterozygous missense mutations in the N-terminal motor or coiled-coil domains of the kinesin family member 5A (KIF5A) gene cause monogenic spastic paraplegia (HSP10) and Charcot-Marie-Tooth disease type 2 (CMT2). Moreover, heterozygous de novo frame-shift mutations in the C-terminal domain of KIF5A are associated with neonatal intractable myoclonus, a neurodevelopmental syndrome. These findings, together with the observation that many of the disease genes associated with amyotrophic lateral sclerosis disrupt cytoskeletal function and intracellular transport, led us to hypothesize that mutations in KIF5A are also a cause of amyotrophic lateral sclerosis. Using whole exome sequencing followed by rare variant analysis of 426 patients with familial amyotrophic lateral sclerosis and 6137 control subjects, we detected an enrichment of KIF5A splice-site mutations in amyotrophic lateral sclerosis (2/426 compared to 0/6137 in controls; P = 4.2 × 10−3), both located in a hot-spot in the C-terminus of the protein and predicted to affect splicing exon 27. We additionally show co-segregation with amyotrophic lateral sclerosis of two canonical splice-site mutations in two families. Investigation of lymphoblast cell lines from patients with KIF5A splice-site mutations revealed the loss of mutant RNA expression and suggested haploinsufficiency as the most probable underlying molecular mechanism. Furthermore, mRNA sequencing of a rare non-synonymous missense mutation (predicting p.Arg1007Gly) located in the C-terminus of the protein shortly upstream of the splice donor of exon 27 revealed defective KIF5A pre-mRNA splicing in respective patient-derived cell lines owing to abrogation of the donor site. Finally, the non-synonymous single nucleotide variant rs113247976 (minor allele frequency = 1.00% in controls, n = 6137), also located in the C-terminal region [p.(Pro986Leu) in exon 26], was significantly enriched in familial amyotrophic lateral sclerosis patients (minor allele frequency = 3.40%; P = 1.28 × 10−7). Our study demonstrates that mutations located specifically in a C-terminal hotspot of KIF5A can cause a classical amyotrophic lateral sclerosis phenotype, and underline the involvement of intracellular transport processes in amyotrophic lateral sclerosis pathogenesis.
- Published
- 2018
4. Sequence variations in C9orf72 downstream of the hexanucleotide repeat region and its effect on repeat-primed PCR interpretation: a large multinational screening study.
- Author
-
Nordin, Angelica, Akimoto, Chizuru, Wuolikainen, Anna, Alstermark, Helena, Forsberg, Karin, Baumann, Peter, Pinto, Susana, de Carvalho, Mamede, Hübers, Annemarie, Nordin, Frida, Ludolph, Albert C., Weishaupt, Jochen H., Meyer, Thomas, Grehl, Torsten, Schweikert, Kathi, Weber, Markus, Burkhardt, Christian, Neuwirth, Christoph, Holmøy, Trygve, and Morita, Mitsuya
- Subjects
DIAGNOSTIC use of polymerase chain reaction ,NUCLEOTIDE sequence ,GENETIC mutation ,FRONTOTEMPORAL dementia ,AMYOTROPHIC lateral sclerosis - Abstract
A large GGGGCC-repeat expansion mutation (HREM) in C9orf72 is the most common known cause of ALS and FTD in European populations. Sequence variations immediately downstream of the HREM region have previously been observed and have been suggested to be one reason for difficulties in interpreting RP-PCR data. Our objective was to determine the properties of these sequence variations with regard to prevalence, the range of variation, and effect on disease prognosis. We screened a multi-national cohort (n = 6981) for the HREM and samples with deviant RP-PCR curves were identified. The deviant samples were subsequently sequenced to determine sequence alteration. Our results show that in the USA and European cohorts (n = 6508) 10.7% carried the HREM and 3% had a sequence variant, while no HREM or sequence variants were observed in the Japanese cohort (n = 473). Sequence variations were more common on HREM alleles; however, certain population specific variants were associated with a non-expanded allele.In conclusion, we identified 38 different sequence variants, most located within the first 50 bp downstream of the HREM region. Furthermore, the presence of an HREM was found to be coupled to a lower age of onset and a shorter disease survival, while sequence variation did not have any correlation with these parameters. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
5. A novel phosphorylation site mutation in profilin 1 revealed in a large screen of US, Nordic, and German amyotrophic lateral sclerosis/frontotemporal dementia cohorts
- Author
-
Ingre, Caroline, Landers, John E., Rizik, Naji, Volk, Alexander E., Akimoto, Chizuru, Birve, Anna, Hübers, Annemarie, Keagle, Pamela J., Piotrowska, Katarzyna, Press, Rayomand, Andersen, Peter Munch, Ludolph, Albert C., and Weishaupt, Jochen H.
- Subjects
- *
PHOSPHORYLATION , *AMYOTROPHIC lateral sclerosis , *GENETIC mutation , *NEURODEGENERATION , *FRONTOTEMPORAL dementia , *POLYMERIZATION - Abstract
Abstract: Profilin 1 is a central regulator of actin dynamics. Mutations in the gene profilin 1 (PFN1) have very recently been shown to be the cause of a subgroup of amyotrophic lateral sclerosis (ALS). Here, we performed a large screen of US, Nordic, and German familial and sporadic ALS and frontotemporal dementia (FTLD) patients for PFN1 mutations to get further insight into the spectrum and pathogenic relevance of this gene for the complete ALS/FTLD continuum. Four hundred twelve familial and 260 sporadic ALS cases and 16 ALS/FTLD cases from Germany, the Nordic countries, and the United States were screened for PFN1 mutations. Phenotypes of patients carrying PFN1 mutations were studied. In a German ALS family we identified the novel heterozygous PFN1 mutation p.Thr109Met, which was absent in controls. This novel mutation abrogates a phosphorylation site in profilin 1. The recently described p.Gln117Gly sequence variant was found in another familial ALS patient from the United States. The ALS patients with mutations in PFN1 displayed spinal onset motor neuron disease without overt cognitive involvement. PFN1 mutations were absent in patients with motor neuron disease and dementia, and in patients with only FTLD. We provide further evidence that PFN1 mutations can cause ALS as a Mendelian dominant trait. Patients carrying PFN1 mutations reported so far represent the “classic” ALS end of the ALS-FTLD spectrum. The novel p.Thr109Met mutation provides additional proof-of-principle that mutant proteins involved in the regulation of cytoskeletal dynamics can cause motor neuron degeneration. Moreover, this new mutation suggests that fine-tuning of actin polymerization by phosphorylation of profilin 1 might be necessary for motor neuron survival. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.